Skip to main content
MSF logo
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
Medicines shouldn’t be a luxury Take action
Get involved
Our campaigns

Latest Press Releases

Latest Press Releases

OCP MSF Hepatitis C clinic in Preah Kossamak Hospital, Phnom Penh, Cambodia Photograph by Dean Irvine
Press release
Press release |
26 January 2015
Hepatitis C Intellectual property and trade

MSF response to Gilead announcement on inclusion of hepatitis C drug GS-5816 in voluntary licence

3 min
Press release |
21 January 2015
Intellectual property and trade
India

Ahead of Obama visit, MSF warns US pressure on India could impact access to medicines for millions

DESCRIPTION:MSF stunt in Berlin outside the venue of the Gavi replenishment meeting, demanding GSK and Pfizer to reduce their price for the pneumococcal vaccine to $5 per child. The stunt involves world leaders spinning a wheel of chance in which - when it comes to the PCV vaccine - pharma almost always wins. Photograph by Stephanie Pilick
Press release
Press release |
20 January 2015
Vaccines

MSF response to GSK and Pfizer’s statement on the pneumonia vaccine (pneumococcal conjugate vaccine, PCV)

2 min
MSF held the first of three rounds of a mass vaccination campaign in Adjumani district of northern Uganda to protect children from deadly respiratory infections, July 2014. Photograph by Markel Redondo
Press release
Press release |
19 January 2015
Vaccines

MSF calls on GSK and Pfizer to slash pneumo vaccine price to $5 per child for poor countries ahead of donor meeting

5 min
DNP+ Protesting Photograph by Siddharth Singh
Press release
Press release |
14 January 2015
Hepatitis C Intellectual property and trade
India

Gilead denied patent for hepatitis C drug sofosbuvir in India

5 min
Emergency coordinator Anja Wolz (centre) reminds MSF International President Dr Joanne Liu (right) to adjust goggles so that it fits comfortably and securely. Photograph by P.K. Lee Photograph by P.K. Lee
Press release
Press release |
07 January 2015
Tropical & neglected diseases
Liberia

Oxford University begins trial of possible Ebola treatment at MSF Treatment Centre in Liberia

Press release |
15 December 2014
Intellectual property and trade
India

MSF responds to Indian Supreme Court decision upholding production of affordable cancer drug

Press release |
12 December 2014

MSF response to Janssen’s bedaquiline donation announcement

  • Load More
Navigate
  • About MSF Access
  • Contact us
  • Get involved
  • Our work
  • Resources
  • Search
Get updates
  • Sign up for our newsletter
  • Privacy & data protection information
Contact

MSF Access
Médecins Sans Frontières
140 Route de Ferney
1202 Geneva, Switzerland
Phone:+41 22 849 8484
E-mail: [email protected]

Follow us

  • X
  • Facebook
  • YouTube
  • Medium
Medicines Shouldn't Be A Luxury